Díaz-Torné, César <br/><br/>
Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.  [electronic resource] 

 -  Immunology  Jul 2014 
 - 354-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2567 
<br/><br/><label>Standard No.: </label>10.1111/imm.12212  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--pharmacology<br/>Antigens, CD19--immunology<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Rheumatoid--blood<br/>Female<br/>Humans<br/>Interleukin-15--antagonists & inhibitors<br/>Male<br/>Middle Aged<br/>Rituximab